Anette Sommer is a biochemist by training and has more than 20 years of experience in Pharma R&D. Anette is the WWRDM / Emerging Science & Innovation – Lead Oncology Europe at Pfizer. In this role, she is responsible for search and evaluation of novel opportunities for preclinical stage cancer therapeutics in Europe.

Prior to joining Pfizer, Anette held several positions in drug discovery at Schering AG and Bayer AG, Berlin, Germany. During her career, she moved several drug candidates for oncology into development and was involved in in-licensing and out-licensing activities and supported external academic alliances and consortia. Her career included a PostDoc at the pharmaceutical company Schering AG in Berlin, Germany. She obtained her PhD at the Medical School Hannover. Prior to this, she studied biochemistry at the Universities of Hannover (Germany) and Glasgow (UK). Anette is co-author of >50 scientific publications and >10 patent applications.